Inhibition of neuroblastoma-induced angiogenesis by fenretinide

被引:50
作者
Ribatti, D
Alessandri, G
Baronio, M
Raffaghello, L
Cosimo, E
Marimpietri, D
Montaldo, PG
De Falco, G
Caruso, A
Vacca, A
Ponzoni, M
机构
[1] Univ Bari, Policlin Bari, Dept Human Anat & Histol, I-70124 Bari, Italy
[2] Univ Brescia, Inst Microbiol, Brescia, Italy
[3] G Gaslini Childrens Hosp, Lab Oncol, Genoa, Italy
[4] Univ Bari, Dept Biomed Sci & Human Oncol, Bari, Italy
关键词
angiogenesis; anti-angiogenesis; fenretinide; neuroblastoma;
D O I
10.1002/ijc.1441
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Retinoids are a class of natural or synthetic compounds that participate in the control of cell proliferation, differentiation and fetal development. The synthetic retinoid fenretinide (HPR) inhibits carcinogenesis in various animal models. Retinoids have also been suggested to be effective inhibitors of angiogenesis. The effects of HPR on certain endothelial cell functions were investigated in vitro, and its effects on angiogenesis was studied in vivo, by using the chorioallantoic membrane (CAM) assay. HPR inhibited vascular endothelial growth factor- (VEGF-) and fibroblast growth factor-2- (FGF-2)-induced endothelial cell proliferation without affecting endothelial motility; moreover, HPR inhibited growth factor-induced angiogenesis in the CAM assay. Furthermore, a significant antiangiogenic potential of HPR has also been observed in neuroblastoma (NB) biopsy-induced angiogenesis in vivo. We previously demonstrated that supernatants derived from NB cell lines stimulated endothelial cell proliferation. In the present study, we found that this effect was abolished when NB cells were incubated in the presence of HPR. VEGF- and FGF-2-specific ELISA assays, performed on both NB cells derived from conditioned medium and cellular extracts, indicated no consistent effect of HPR on the level of these angiogenic cytokines. Moreover, RT-PCR analysis of VEGF- and FGF-2 gene expression confirmed the above lack of effect. HPR was also able to significantly repress the spontaneous growth of endothelial cells, requiring at least 48-72 hr of treatment with HPR, followed by a progressive accumulation of cells in G, at subsequent time points. Finally, immunohistochemistry experiments performed in the CAM assay demonstrated that endothelial staining of both VEGF receptor 2 and FGF-2 receptor-2 was reduced after implantation of HPR-loaded sponges, as compared to control CAMs. These data suggest that HPR exerts its antiangiogenic activity through both a direct effect on endothelial cell proliferative activity and an inhibitory effect on the responsivity of the endothelial cells to the proliferative stimuli mediated by angiogenic growth factors. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 54 条
  • [1] ALBINO AP, 1991, CANCER RES, V51, P4815
  • [2] Alessandri G, 1998, LAB INVEST, V78, P127
  • [3] ALESSANDRI G, 1985, METASTASIS, V6, P145
  • [4] Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: Association with tumor progression and clinical outcome
    Ara, T
    Fukuzawa, M
    Kusafuka, T
    Komoto, Y
    Oue, T
    Inoue, M
    Okada, A
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1998, 33 (08) : 1272 - 1278
  • [5] GROWTH SUPPRESSION OF HUMAN BREAST-CARCINOMA CELLS IN CULTURE BY N-(4-HYDROXYPHENYL)RETINAMIDE AND ITS GLUCURONIDE AND THROUGH SYNERGISM WITH GLUCARATE
    BHATNAGAR, R
    ABOUISSA, H
    CURLEY, RW
    KOOLEMANSBEYNEN, A
    MOESCHBERGER, ML
    WEBB, TE
    [J]. BIOCHEMICAL PHARMACOLOGY, 1991, 41 (10) : 1471 - 1477
  • [6] MODULATION OF ENDOTHELIAL-CELL SHAPE AND GROWTH BY RETINOIDS
    BRAUNHUT, SJ
    PALOMARES, M
    [J]. MICROVASCULAR RESEARCH, 1991, 41 (01) : 47 - 62
  • [7] Carlevaro MF, 2000, J CELL SCI, V113, P59
  • [8] Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
    Cheng, SY
    Huang, HJS
    Nagane, M
    Ji, XD
    Wang, DG
    Shih, CCY
    Arap, W
    Huang, CM
    Cavenee, WK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) : 8502 - 8507
  • [9] EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
  • [10] 2-G